PS Ratio
N/A
Wed, 27 Nov 2024 22:27:57 GMT
Summary:
Inhibikase Therapeutics price to sales ratio is not available.IKT PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT PS Ratio Performance
PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | - | +11.6% | +11.6% | - |
1 m1 month | - | +7.3% | +9.6% | - |
3 m3 months | - | +85.7% | +1571.8% | - |
6 m6 months | - | +36.8% | +1060.3% | - |
ytdytd | - | +109.7% | +2177.4% | - |
1 y1 year | - | +198.8% | +3152.3% | - |
5 y5 years | - | - | - | - |
IKT PS Ratio High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | ||||
3 m | 3 months | ||||
6 m | 6 months | ||||
1 y | 1 year | ||||
3 y | 3 years | 16.39 | 10.62 | ||
5 y | 5 years | 129.49 | 10.62 | ||
alltime | all time | 129.49 | 10.62 |
Inhibikase Therapeutics PS Ratio History
Date | Value |
---|
Date | Value |
---|---|
2020 | 99.28 |
FAQ
- What is the all time high PS ratio for Inhibikase Therapeutics?
What is the all time high PS ratio for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high price to sales ratio is 129.49